Molecular Testing for GI Pathogens: Cost-Effectiveness, Clinical Impact and Lab Implementation

Diarrheal infections represent a significant healthcare burden worldwide. Clinically, treatment varies depending on the identity of the stool pathogen, so rapid and accurate identification of pathogenic bacteria and viruses from a stool specimen is critical. Conventional diagnostics weigh down laboratories with extensive hands-on time, low sensitivity, and long turnaround times, which fall short of meeting the time-sensitive needs of clinicians to inform treatment decisions. Multiplexed molecular methods are very well-suited to address this diagnostic need. This complementary webinar will provide an in-depth analysis of the clinical and economic value of molecular testing for GI pathogens and describe the impact implementation of these tests can have on laboratory efficiency.

Embed

Discussion

Related Videos